GS1’s EPCIS communication standard might play in shipment tracking
Both Axway (Scottsdale, AZ) and IBM (Armonk, NY) have invested heavily in developing standards-based track-and-trace systems to meet future drug pedigree requirements. Both have installations where such tracking is being initiated (the most recent being IBM’s at Golden State Medical Supply—see related item). And now, both are looking to capitalize on the data-gathering and transmitting capabilities of their solutions to tackle another pharma supply-chain problem: cold chain management.
“Historically, cold chain management has been handled well for point-to-point shipments—monitoring a product that moves form point A to point B, and then downloading the temperature profile data,” says Kim Loughead, solution marketing manager at Axway. “What we’re examining is the usefulness of aggregating data to provide end-to-end visibility, so that problems like making in-transit adjustments can be carried out.” The business case for this is not completely clear yet: major carriers such as UPS or DHL offer tracking systems, and have end-to-end delivery capabilities; conversely, other freight-forwarding companies have developed IT systems to link up the tracking databases of multiple carriers when a shipment has been handed off. At the product/package level, temperature-monitoring vendors have software that collects and organizes the data from their dataloggers.
But none of these are in use currently to deliver the end-to-end visibility so that multiple clients—such as regulatory affairs officers of pharma companies as well as the transportation or supply chain managers—can easily gain access to the data. The track-and-trace technology was developed originally to meet now-postponed regulatory standards and to address the threats of drug diversion or counterfeiting in the supply chain. Paul Chang, emerging technologies business strategist at IBM, told the audience of the CBI Drug Tracking Conference (Philadelphia, Apr. 28-29) that not only is IBM’s Traceability Server already in use for managing food deliveries in retail supermarkets, but it is about to be evaluated by a major pharma wholesaler to manage cold-chain reporting. “It just makes sense to apply this technology when you have to collect data from many different sources, but want to look at it as a whole,” he said.
For its part, Axway’s Loughead says that they are in discussions with several logistics providers and pharma manufacturers, and are planning to start up a pilot this summer.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.